1-20 of 37
David Cella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Quality and timing of patient-reported outcome reports in randomized controlled trials (RCTs) of patients with lymphoid malignancies: Analysis of 83 RCTs published between 2015 and 2025

Free
Fabio Efficace, David Cella, Neil Aaronson, Gary S. Collins, Francesco Sparano, Rajshekhar Chakraborty, Darshi Shah, Veer Shah, Chiara Pallisco, Giorgia Novero, Valentina Ponti, Paola Sabbadini, Anna Amela Valsecchi, Massimo Di Maio, Amelie Anota
Journal: Blood
Blood (2025) 146 (Supplement 1): 4408.
https://doi.org/10.1182/blood-2025-4408
Published: 2025
Journal Articles

Comprehensive analyses of patient-reported outcomes from the phase 3 VERIFY study of rusfertide or placebo plus current standard of care for polycythemia vera

Free
Aniket Bankar, Andrew Kuykendall, Naveen Pemmaraju, Kristen Pettit, Joseph Shatzel, Alessandro Lucchesi, Valentín García Gutiérrez, Harinder Gill, Joseph Scandura, Francesca Palandri, Matthew Reaney, Cristina Ivanescu, Christina Daskalopoulou, Phil Dinh, Sarita Khanna, Suneel Gupta, Arturo Molina, David Cella
Journal: Blood
Blood (2025) 146 (Supplement 1): 5588.
https://doi.org/10.1182/blood-2025-5588
Published: 2025
Journal Articles

Reasons for treatment discontinuation in multiple myeloma: Insights from the PREAMBLE registry

Free
Ravi Vij, Mark Fiala, David Cella, Brian Durie, David Kuter, Claudio Cerchione, Kamaraj Karunanithi, Jing Bo Li, Amanda Crosbie, Gabriela Hernandez-Rivera, Antoine Tinel, Thomas S. Marshall, Meghan Podolsky, Karthik Ramasamy
Journal: Blood
Blood (2025) 146 (Supplement 1): 6345.
https://doi.org/10.1182/blood-2025-6345
Published: 2025
Journal Articles

Treatment Patterns and Outcomes for Patients with Newly Diagnosed Multiple Myeloma Post-Stem Cell Transplantation Who Received Lenalidomide As First Line Maintenance Therapy (PREAMBLE)

Free
Ravi Vij, Suvina Amin, Jin Gu, Thomas S. Marshall, Susan Fish, Sujith Dhanasiri, Gabriela Hernandez, David Cella, Hartmut Goldschmidt, Karthik Ramasamy
Journal: Blood
Blood (2023) 142 (Supplement 1): 3786.
https://doi.org/10.1182/blood-2023-178500
Published: 2023
Journal Articles

Efficacy of Sutimlimab in Improving FACIT-Fatigue Scores in Patients with Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cadenza (Part A) Study

Free
Alexander Roeth, Ilene Weitz, Yasutaka Ueda, Sylvie Bozzi, Reena Patel, Alia Karaouni, Ronnie Yoo, David Cella, Jennifer Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5558.
https://doi.org/10.1182/blood-2023-181563
Published: 2023
Journal Articles

Sutimlimab Provides Sustained Improvements in Patient-Reported Outcomes and Quality of Life in Patients with Cold Agglutinin Disease: Open-Label Extension of the Randomized, Phase 3 Cadenza Study

Free
Alexander Roeth, Catherine M. Broome, Wilma Barcellini, Bernd Jilma, Quentin A. Hill, David Cella, Tor Henrik Anderson Tvedt, Masaki Yamaguchi, Irina Murakhovskaya, Michelle Lee, Frank Shafer, Marek Wardecki, Jennifer Wang, Ronnie Yoo, Jerome Mshijid, Ilene C. Weitz
Journal: Blood
Blood (2022) 140 (Supplement 1): 70–72.
https://doi.org/10.1182/blood-2022-159966
Published: 2022
Journal Articles

Relationship of Hydroxyurea Adherence to Depression and Fatigue Among Children and Adolescents with Sickle Cell Disease: A Longitudinal Cohort Study

Free
Sherif M. Badawy, Kathryn King, Olivia E. Atherton, Daniel Mroczek, Alexis A. Thompson, David Cella, Tonya M. Palermo, Jane L. Holl, Robert I. Liem
Journal: Blood
Blood (2021) 138 (Supplement 1): 3104.
https://doi.org/10.1182/blood-2021-149902
Published: 2021
Journal Articles

Symptoms and Impacts Reported By Patients with Acute Myeloid Leukemia (AML) in Remission Post-Stem Cell Transplant

Free
David Cella, Thomas W. LeBlanc, Manasee V. Shah, Anna de la Motte, Farah Toublan, Kimberly Kelly
Journal: Blood
Blood (2021) 138 (Supplement 1): 278.
https://doi.org/10.1182/blood-2021-145393
Published: 2021
Journal Articles

Clinically Important Difference for the FACIT-Fatigue Scale in Paroxysmal Nocturnal Hemoglobinuria: A Derivation from International PNH Registry Patient Data

Free
David Cella, Peter Johansson, Yasutaka Ueda, Ioannis Tomazos, Philippe Gustovic, Alice Wang, Ami S. Patel, Hubert Schrezenmeier
Journal: Blood
Blood (2021) 138 (Supplement 1): 1952.
https://doi.org/10.1182/blood-2021-153127
Published: 2021
Journal Articles

Patient-Reported Outcomes Among Patients with High-Risk Untreated Follicular Lymphoma (FL) Randomized to Bendamustine/Rituximab (BR) or Bendamustine/Rituximab with Bortezomib (BVR) Therapy: Results from the ECOG-ACRIN E2408 Study

Free
Giselle K. Perez, PhD, Fangxin Hong, PhD, Andrew M. Evens, DO,MMSc, Thomas M. Habermann, MD, Ranjana Advani, MD, Stephen M. Ansell, MD PhD, Puneet S. Cheema, MD, Philip A. Dy, MD, Timothy E. O'Brien, MD, Jane N. Winter, MD, Julie E. Chang, MD, David Cella, PhD, Brad S. Kahl, MD, Lynne I. Wagner, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-140502
Published: 2020
Journal Articles

Pain and Opioid Use in Patients with FLT3 Mutation-Positive Relapsed/Refractory AML: A Subanalysis of Patient-Reported Outcomes from the Admiral Trial

Free
David Cella, PhD, Ellen Ritchie, MD, Arnaud Pigneux, MD PhD, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V. Shah, MPH
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-134389
Published: 2020
Journal Articles

Improvements in Fatigue Correlate with Changes in Clinical and Hematological Outcomes: Post Hoc Analyses from the Pegasus Study

Free
David Cella, PhD, William R. Lenderking, PhD, Sujata P. Sarda, PhD, Scott B. Baver, PhD, Mohamed Hamdani, MS, Ray Hsieh, MS, Shannon Shaffer, MS, Alexander Röth, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-142354
Published: 2020
Journal Articles

Quality-of-Life Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Treated with Elotuzumab Plus Lenalidomide/Dexamethasone or Lenalidomide/Dexamethasone: Final Analysis of the Phase 3 ELOQUENT-2 Study

Free
David Cella, PhD, Jan McKendrick, Harrison Davis, Ravi Vij, MBBS, Clara Chen, PhD BS, MS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2190.
https://doi.org/10.1182/blood-2019-122668
Published: 2019
Journal Articles

Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy-Fatigue Scale (FACIT-Fatigue) in Patients with Chronic Lymphocytic Leukemia (CLL)

Free
Daniel Eek, PhD, Cristina Ivanescu, PhD, Leanne Kool-Houweling, MSc, David Cella, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4763.
https://doi.org/10.1182/blood-2019-123056
Published: 2019
Journal Articles

The Relationship between Transplant Status and Patient-Reported Outcomes in Patients with FLT3 -Mutated Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Free
David Cella, PhD, Ellen K. Ritchie, MD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 3850.
https://doi.org/10.1182/blood-2019-123790
Published: 2019
Journal Articles

The Relationship between Hospitalization and Patient-Reported Outcomes (PROs) in Patients with FLT3 -Mutated ( FLT3 mut+ ) Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML): Results from the Phase 3 Admiral Study

Free
Ellen K. Ritchie, MD, David Cella, PhD, Francesco Fabbiano, Arnaud Pigneux, Yoshinobu Kanda, MD PhD, Cristina Ivanescu, PhD, Bhavik J. Pandya, PharmD, Manasee V Shah, MPH
Journal: Blood
Blood (2019) 134 (Supplement_1): 1332.
https://doi.org/10.1182/blood-2019-123779
Published: 2019
Journal Articles

Survival in Patients with Relapsed/Refractory Multiple Myeloma: Outcomes after 4 Years of the Ongoing Multinational Observational Preamble Study

Free
Gordon Cook, David Cella, PhD, Clara Chen, PhD BS, MS, Catherine Davis, PharmD, Brian GM Durie, MD, Hartmut Goldschmidt, MD, David J. Kuter, MD, Philippe Moreau, Ravi Vij, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3285.
https://doi.org/10.1182/blood-2018-99-112081
Published: 2018
Journal Articles

Patient-Reported Outcomes Validation of the FACT-Leu in Acute Myeloid Leukemia: A Review of Baseline Characteristics in AML2002

Free
Jianming He, PhD, Renee Pierson, MBA, Christina Loefgren, MD PhD, David Cella, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3590.
https://doi.org/10.1182/blood-2018-99-114635
Published: 2018
Journal Articles

Effect of Nivolumab on Patient-Reported Outcomes in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma after Autologous Transplantation: Results from the Multicohort Phase 2 Checkmate 205 Study

Free
Andreas Engert, MD, Fiona Taylor, Bryan Bennett, Clara Chen, PhD BS, MS, Kim Cocks, Jeffrey McDonald, Erin Mann, Mariana Sacchi, David Cella, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3441.
https://doi.org/10.1182/blood.V130.Suppl_1.3441.3441
Published: 2017
Journal Articles

What Are the Most Important Symptoms and Concerns of Patients with Indolent Non-Hodgkin's Lymphoma? Content Validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy Lymphoma Symptom Index-18 (NFLymSI-18)

Free
Karen Kaiser, PhD, Sara Shaunfield, PhD, Kimberly Webster, MA, Karen Keating, MBA, Lara Boyken, Sara Duffey, Jessica Yarber, MD, David Cella, PhD
Journal: Blood
Blood (2016) 128 (22): 4792.
https://doi.org/10.1182/blood.V128.22.4792.4792
Published: 2016